DK1297006T3 - Regulering af human prostasin-lignende serinprotease - Google Patents

Regulering af human prostasin-lignende serinprotease

Info

Publication number
DK1297006T3
DK1297006T3 DK01967085T DK01967085T DK1297006T3 DK 1297006 T3 DK1297006 T3 DK 1297006T3 DK 01967085 T DK01967085 T DK 01967085T DK 01967085 T DK01967085 T DK 01967085T DK 1297006 T3 DK1297006 T3 DK 1297006T3
Authority
DK
Denmark
Prior art keywords
human prostasin
regulation
serine protease
prostasin
reagents
Prior art date
Application number
DK01967085T
Other languages
English (en)
Inventor
Yonghong Xiao
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1297006T3 publication Critical patent/DK1297006T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01967085T 2000-06-23 2001-06-22 Regulering af human prostasin-lignende serinprotease DK1297006T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21347400P 2000-06-23 2000-06-23
US27761201P 2001-03-22 2001-03-22

Publications (1)

Publication Number Publication Date
DK1297006T3 true DK1297006T3 (da) 2006-05-22

Family

ID=26908122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01967085T DK1297006T3 (da) 2000-06-23 2001-06-22 Regulering af human prostasin-lignende serinprotease

Country Status (9)

Country Link
US (2) US7049420B2 (da)
EP (1) EP1297006B1 (da)
AT (1) ATE317399T1 (da)
AU (1) AU2001287555A1 (da)
DE (1) DE60117155T2 (da)
DK (1) DK1297006T3 (da)
ES (1) ES2258099T3 (da)
PT (1) PT1297006E (da)
WO (1) WO2001098466A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485957B1 (en) * 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
WO2006063462A1 (en) * 2004-12-13 2006-06-22 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485957B1 (en) * 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
JP2003524413A (ja) * 1999-10-07 2003-08-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド プラスミノーゲン様ポリヌクレオチド、ポリペプチド、および抗体
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
EP1292684A2 (en) * 2000-06-16 2003-03-19 Incyte Genomics, Inc. Proteases
WO2001098467A2 (en) * 2000-06-23 2001-12-27 Bayer Aktiengesellschaft Regulation of human prostasin-like serine protease

Also Published As

Publication number Publication date
US20060154293A1 (en) 2006-07-13
PT1297006E (pt) 2006-05-31
EP1297006B1 (en) 2006-02-08
WO2001098466A3 (en) 2002-08-15
DE60117155T2 (de) 2006-09-28
AU2001287555A1 (en) 2002-01-02
ES2258099T3 (es) 2006-08-16
ATE317399T1 (de) 2006-02-15
DE60117155D1 (de) 2006-04-20
US7049420B2 (en) 2006-05-23
US20040141962A1 (en) 2004-07-22
WO2001098466A2 (en) 2001-12-27
US7538205B2 (en) 2009-05-26
EP1297006A2 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
ATE394491T1 (de) Regulierung einer humanen transmembran- serinprotease
Jabłońska-Trypuć et al. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
Ginestra et al. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells
NO20025376L (no) Nye multicykliske forbindelser og anvendelser derav
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
PT1202743E (pt) Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
Han et al. Tumor necrosis factor-α-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase
Chen et al. Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts.
ATE233552T1 (de) Thiol-sulfonen als metalloproteinaseinhibitoren
ATE526399T1 (de) Neue biologische einheiten und deren verwendung
HRP20050382B1 (hr) Novi pirimidin-4,6-dikarboksamidi za selektivnu inhibiciju kolagenaza
DE60132190D1 (de) Mutierte version der arginin deiminase
PT1071704E (pt) Novos inibidores e reguladores negativos das metaloproteinases da matriz
Oliveira et al. Simplified procedures for the isolation of HF3, bothropasin, disintegrin-like/cysteine-rich protein and a novel PI metalloproteinase from Bothrops jararaca venom
DK1297006T3 (da) Regulering af human prostasin-lignende serinprotease
WO2001096378A3 (en) Human epithin-like serine protease
WO2001098340A3 (en) Regulation of human mast cell protease 6-like enzyme
WO2001098467A3 (en) Regulation of human prostasin-like serine protease
WO2002000702A3 (en) Regulation of human epidermis-specific serine protease
WO2001079466A3 (en) Regulation of human epithin-like serine protease
WO2001072973A3 (en) Regulation of human heparanase-like enzyme
WO2001085959A3 (en) Regulation of human lysostaphin-like protease
WO2001062941A3 (en) Regulation of human gelatinase b-like enzyme 2
WO2002012461A3 (en) Regulation of human membrane-type serine protease